Hyundai Pharmaceutical Co., Ltd. (KRX:004310)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,110
+10 (0.08%)
At close: Feb 25, 2026
Market Cap362.85B +277.3%
Revenue (ttm)108.14B +5.8%
Net Income1.41B
EPS60.34
Shares Out27.68M
PE Ratio217.28
Forward PEn/a
Dividend30.00 (0.23%)
Ex-Dividend DateMar 3, 2026
Volume2,007,992
Average Volume4,488,191
Open13,200
Previous Close13,100
Day's Range13,000 - 13,940
52-Week Range2,995 - 15,960
Beta0.82
RSI58.37
Earnings Daten/a

About Hyundai Pharmaceutical

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive sy... [Read more]

Sector Healthcare
Founded 1965
Employees 393
Stock Exchange Korea Stock Exchange
Ticker Symbol 004310
Full Company Profile

Financial Performance

Financial Statements